Mediland Pharm Share Price and Company Fundamentals



Price
$0.072
Change
0.000 (0.000%)
52 week
0.043 - 0.145

Last traded: Today at 12:22 AM

Mediland Pharm Limited, together with subsidiaries, engages in the retail sale of health, beauty, and wellness products in Australia and New Zealand. The company's stores also offers luxury products, such as opal and pink diamond jewelry pieces, souvenirs and gifts, luxurious bedding and rugs. It operates through one direct store in Australia; one store in Auckland, New Zealand; six franchise shops in China; three WeChat accounts; and four e-commerce platforms. The company was founded in 2002 and is headquartered in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

6.00

Dividend yield

Beta

0.68

Market cap

$22.52M

Enterprise value

$18.96M

Company profile

Primary activitiesOperates retail outlets that service inbound Chinese visitors that come to Australia via organised tours arranged under the Approved Destination Status scheme.
Industry / SectorHousehold & Personal Products / Consumer Defensive
Websitehttp://www.medilandpharm.com.au
Mailing address227 Elizabeth Street Suite 4 Level 19 Sydney NSW 2000 Australia
Phone / Fax61 2 9261 1594 /
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

Mediland Pharm does not pay dividends.

Company Executives

As of May 2021, following are the company executives and directors listed on Mediland Pharm.

NameTitleAgeTotal Pay
Mr. Yeshween MudaliarMD & Director109.71k
Ms. Jessie TaoChief Financial Officer114.39k
Mr. Jhon ShenExec. Director56.86k
Ms. Indira NaiduCompany Sec.35.3k

Profitability and management effectiveness

Profit margin

-212.16%

Operating margin

-127.37%

Return on assets

-27.70%

Return on equity

-117.25%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Mediland Pharm is 22.52M and its enterprise value is 18.96M. The enterprise value to revenue ratio of MPH is 4.09.

The MPH's stocks Beta value is 0.68 making it 32% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Mediland Pharm (MPH)

Mediland Pharm (ASX:MPH) Frequently Asked Questions

1. What is Mediland Pharm's Stock Symbol?

Mediland Pharm trades on ASX under the ticker symbol "MPH".

2. What is Mediland Pharm's stock price today?

One share of MPH stock can currently be purchased for approximately $0.072.

3. How can I contact Mediland Pharm?

Mediland Pharm's mailing address is 227 Elizabeth Street Suite 4 Level 19 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9261 1594.

4. What is Mediland Pharm's official website?

The official website of Mediland Pharm is http://www.medilandpharm.com.au.

5. Which share registry manages Mediland Pharm's stock?

Mediland Pharm's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.